Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listSunifiram

Sunifiram

  • CAS NO.:314728-85-3
  • Empirical Formula: C14H18N2O2
  • Molecular Weight: 246.3
  • MDL number: MFCD04112755
  • EINECS: 1312995-182-4
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-10-28 16:48:35
Sunifiram Structural

What is Sunifiram?

Description

Sunifiram (DM-235) is a synthetic derivative of piracetam, although due to breaking the pyrrolidone backbone it is no longer in the racetam class of drugs (yet by being derived from them, it is still commonly associated with this class).
Sunifiram has mechanisms similar to nefiracetam in the hippocampus, and similar to that drug sunifiram shows anti-amnesiac properties and is potentially a cognitive enhancer. Its anti-amnesiac activity is several orders of magnitude greater than piracetam on a per weight basis, and preliminary evidence suggest it has a similarly low toxicity profile.

The Uses of Sunifiram

Sunifiram is a potent nootropic agent.

What are the applications of Application

DM 235 is a strong nootropic agent

Synthesis Reference(s)

Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers.
DOI: 10.1016/j.bmc.2009.08.055
synthesis of Sunifiram
Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening
DOI: 10.1080/14756366.2022.2068147

Side Effects

While initial research suggests that sunifiram is virtually non-toxic and doesn’t produce any notable side effects, it’s important to note how little research has been conducted on this compound. For this reason, it’s incredibly important that you begin with a low dosage before ramping up to a higher one, and pay close attention to any noted side effects you experience.
Based on anecdotal evidence, some sunifiram users have experienced side effects such as:
Headache
Hot flashes
Difficulty sleeping
Manic feelings
These side effects seem only to be mentioned with dosages outside of the 5-10mg range, with higher doses producing more pronounced side effects. If you find that you’re experiencing side effects as you up your dosage, ramp down your dosage to a level where no side effects are present.

Mode of action

Sunifiram enhances NMDA-dependent signaling by increasing PKCα phosphorylation, at a dosage range of 10-100nM. This mechanism of action is dependent on the availability of the glycine binding site and Sunifiram has been shown to act as an antagonist to glycine at a concentration of 300μM.
Furthermore, the increased activity of AMPA receptor activation has been associated with increased CAMKII and PKCα phosphorylation. Although studies have confirmed that intracellular proteins like CAMKII and PKCα are activated after Sunifiram administration, other proteins like CaMKIV and ERK remain unaffected.
A brief summary of the mechanism of action, as it is currently understood, is that Sunifiram acts on the NMDA receptor’s glycine binding site, which results in increased signaling and activation of CAMKII and PKCα proteins and the subsequent positive regulation of AMPA receptors.
Furthermore, animal studies have indicated that a dosage of 0.01mg/kg increases acetylcholine release by up to 200% within one hour of injection, in rat prefrontal cortex. This effect is not seen at a higher dosage of 1mg/kg.

References

[1] Agha, Khalid A. et al. "Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening." Journal of Enzyme Inhibition and Medicinal Chemistry 37 (2022): 1241–1256. DOI: 10.1080/14756366.2022.2068147
[2] Moriguchi, Shigeki et al. "Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine‐binding site of N‐methyl‐D‐aspartate receptor." Hippocampus 23 (2013). DOI: 10.1002/hipo.22150

Properties of Sunifiram

Melting point: 92 - 94°C
Boiling point: 442.0±38.0 °C(Predicted)
Density  1.154±0.06 g/cm3 (20 ºC 760 Torr)
storage temp.  2-8°C
solubility  H2O: soluble24mg/mL
pka 0.08±0.70(Predicted)
form  solid
color  white

Safety information for Sunifiram

Computed Descriptors for Sunifiram

Related products of tetrahydrofuran

You may like

Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.